Active Pharmaceutical Ingredient

Belimumab (CAS 356547-88-1) API Manufacturer & Supplier in India

Also known as: Benlysta (brand)

CAS: 356547-88-1 BLyS Inhibitor Autoimmune Bulk Supply Available
Belimumab API Manufacturer India | Mediocon Inc
Belimumab — Pharmaceutical Grade API

Product Overview

CAS No: 356547-88-1  |  MF: N/A (Monoclonal Antibody)  |  MW: ~147 kDa

Belimumab is a monoclonal antibody that inhibits B-lymphocyte stimulator (BLyS), used in the treatment of active systemic lupus erythematosus (SLE) and lupus nephritis. It reduces the survival of B cells, decreasing autoantibody production. Mediocon Inc supplies pharmaceutical-grade Belimumab for biopharmaceutical manufacturers.

Key Features

  • Anti-BLyS monoclonal antibody
  • IP/BP/EP/USP compliant quality
  • Systemic lupus erythematosus treatment
  • IV and subcutaneous formulations available

Applications

  • SLE IV infusion formulations
  • Subcutaneous auto-injector
  • Lupus nephritis treatment
  • Biopharmaceutical manufacturing

Why Choose Mediocon

  • ISO 9001:2015 & GMP certified manufacturing
  • Consistent batch-to-batch quality with full CoA
  • Export-ready documentation: COO, MSDS, DMF
  • Flexible MOQ for both R&D and commercial scale
  • Dedicated QA support for regulatory filings

Product Specifications

Product NameBelimumab
Also Known AsBenlysta (brand)
CAS Number356547-88-1
Molecular FormulaN/A (Monoclonal Antibody)
Molecular Weight~147 kDa
CategoryImmunology / BLyS Inhibitor / Biologic
AppearanceLyophilized Powder / Solution
GradeIP / BP / EP / USP

Analytical Specifications

ParameterSpecification
Purity≥ 99% (by SEC-HPLC)
EndotoxinNMT 1 EU/mg
BioburdenComplies
IdentificationPeptide Mapping Compliant
Storage2–8°C
PackingAs per requirement

Sourcing, Regulatory & Export Information

Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Belimumab (CAS 356547-88-1) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.

Our Belimumab is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.

Export Markets

  • USA — FDA-registered facility; DMF support available for ANDA/NDA filings
  • Europe — EMA-compliant documentation; CEP/EDMF support on request
  • Africa & Middle East — WHO-GMP certified; competitive pricing for emerging markets
  • Southeast Asia — established logistics network; temperature-controlled shipments
  • India domestic — schedule H/X compliance; all state licensing documentation provided

Quality & Compliance

  • ISO 9001:2015 certified quality management system
  • GMP-certified manufacturing facility, Aurangabad, Maharashtra
  • Full batch traceability from raw material to finished API
  • Stability data available (ICH Q1A guidelines) for regulatory submissions
  • Dedicated QA team for customer audits and regulatory queries

Frequently Asked Questions — Belimumab API

What is the minimum order quantity for Belimumab API?
Mediocon Inc supplies Belimumab with a minimum order quantity of 1 kg (sample packs available for R&D). We accommodate both small R&D quantities and large commercial-scale orders. Contact our sales team at akshay@mediocon.com or +91 9309999757 for a tailored quote.
What pharmacopoeial grades of Belimumab does Mediocon supply?
We supply Belimumab conforming to IP / BP / EP / USP pharmacopoeial standards. Each batch is tested against full pharmacopoeial specifications and released with a Certificate of Analysis. Custom specifications can be accommodated for regulated markets.
What documentation is provided with Belimumab API?
Every shipment of Belimumab comes with: Certificate of Analysis (CoA), MSDS/SDS, Certificate of Origin (COO), and Drug Master File (DMF) support on request. We also provide GMP certification, ISO 9001:2015 compliance documentation, and full regulatory support for filings in USA (FDA), Europe (EMA), and other markets.
What is the lead time and shipping for Belimumab bulk orders?
Standard lead time for Belimumab is 2–4 weeks for standard orders; expedited shipments possible for urgent requirements. We ship to 40+ countries worldwide using approved pharmaceutical-grade packaging (25 kg HDPE drums / aluminium foil bags). All shipments include temperature-controlled logistics options where required by the product's storage conditions.
💬
Mediocon AI
Hello 👋 How can I help you today?